title: Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial.
abstract: BACKGROUND
  Comparisons of the relation of diet with coronary heart disease (CHD) between countries with similar socioeconomic environments have been few. Patients in Australia and New Zealand (n = 9014) who participated in a large secondary prevention trial had significantly different CHD mortality rates.
  
  
  OBJECTIVE
  The objective of this study was to ascertain the effects of nutrient consumption on cardiovascular disease risk in patients from the 2 countries.
  
  
  METHODS
  Nutrient consumption patterns were surveyed in a subgroup of 1077 patients on 3 occasions over 4 y during an intervention trial with a statin.
  
  
  RESULTS
  Within the entire cohort of 9014 patients, the New Zealanders had significantly (40%) more cardiovascular deaths than did the Australians. In the subgroup of 1077 patients, the New Zealanders were found at entry to have eaten significantly more total (69.34 +/- 12.35 compared with 66.45 +/- 12.9 g/d) and saturated (26.23 +/- 8.41 compared with 24.37 +/- 7.36 g/d) fat (P < 0.001 for each) and to have significantly (4%) higher concentrations of LDL cholesterol (3.96 +/- 0.74 compared with 3.8 +/- 0.76 mmol/L; P < 0.001) than did the Australians. At baseline, patients with previous coronary artery bypass grafting had diets that were significantly different from those of patients without previous coronary artery bypass grafting. Relations between nutrients and plasma lipids confirmed the direct effects of saturated fatty acids on LDL cholesterol and of alcohol on plasma triacylglycerol and HDL cholesterol. Dietary counseling throughout the trial led to significant improvements in compliance with guidelines. However, neither the baseline nor the improved 1-y nutrient intakes predicted future changes in cardiovascular events.
  
  
  CONCLUSIONS
  Differences in CHD mortality and in LDL-cholesterol concentrations between 2 populations with similar socioeconomic and cultural backgrounds were consistent with the amounts and types of fats eaten.
authors.affiliation: Baker Heart Research Institute, Melbourne, Australia. paul.nestel@baker.edu.au
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Nestel
authors.forename: Katrine
authors.initials: K
authors.lastname: Baghurst
authors.forename: David M
authors.initials: DM
authors.lastname: Colquhoun
authors.forename: R John
authors.initials: RJ
authors.lastname: Simes
authors.forename: Kirsty
authors.initials: K
authors.lastname: Mehalski
authors.forename: Harvey D
authors.initials: HD
authors.lastname: White
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Tonkin
authors.forename: Adrienne
authors.initials: A
authors.lastname: Kirby
authors.forename: Christine
authors.initials: C
authors.lastname: Pollicino
mesh_terms: D000368:Aged; D000428:Alcohol Drinking / Q000009:adverse effects; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001315:Australia / Q000453:epidemiology; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000209:etiology / Q000401:mortality; D002791:Cholesterol, Dietary / Q000008:administration & dosage*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood*; D015331:Cohort Studies; D004032:Diet; D004034:Diet Surveys; D004041:Dietary Fats / Q000008:administration & dosage*; D015981:Epidemiologic Factors; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009520:New Zealand / Q000453:epidemiology; D017035:Pravastatin / Q000627:therapeutic use; D012307:Risk Factors; D011795:Surveys and Questionnaires; D014280:Triglycerides / Q000097:blood
chemical_list: D000924:Anticholesteremic Agents; D002791:Cholesterol, Dietary; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D004041:Dietary Fats; D014280:Triglycerides; D017035:Pravastatin